{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T21:37:07Z","timestamp":1774042627032,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T00:00:00Z","timestamp":1548720000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1038\/s41440-019-0217-7","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T06:02:32Z","timestamp":1548741752000},"page":"618-627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Hypertension exhibits 5-HT4 receptor as a modulator of sympathetic neurotransmission in the rat mesenteric vasculature"],"prefix":"10.1038","volume":"42","author":[{"given":"Jos\u00e9 \u00c1ngel","family":"Garc\u00eda-Pedraza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Garc\u00eda-Domingo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"G\u00f3mez-Roso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Ruiz-Remolina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Rodr\u00edguez-Barbero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Luisa","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asunci\u00f3n","family":"Mor\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,29]]},"reference":[{"key":"217_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s11906-008-0045-7","volume":"10","author":"RG Victor","year":"2008","unstructured":"Victor RG, Shafiq MM. Sympathetic neural mechanisms in human hypertension. Curr Hypertens Rep. 2008;10:241\u20137.","journal-title":"Curr Hypertens Rep"},{"key":"217_CR2","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1161\/HYPERTENSIONAHA.108.119883","volume":"54","author":"G Grassi","year":"2009","unstructured":"Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension. 2009;54:690\u20137.","journal-title":"Hypertension"},{"key":"217_CR3","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1161\/HYPERTENSIONAHA.111.00633","volume":"61","author":"GF DiBona","year":"2013","unstructured":"DiBona GF. Sympathetic nervous system and hypertension. Hypertension. 2013;61:556\u201360.","journal-title":"Hypertension"},{"key":"217_CR4","first-page":"727","volume":"50","author":"E Sastre","year":"2010","unstructured":"Sastre E, M\u00e1rquez-Rodas I, Blanco-Rivero J, Balfag\u00f3n G. Inervaci\u00f3n perivascular de la arteria mesent\u00e9rica superior: implicaciones fisiopatol\u00f3gicas. Rev Neurol. 2010;50:727\u201337.","journal-title":"Rev Neurol"},{"key":"217_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/bjaceaccp\/mkv017","volume":"16","author":"D Harper","year":"2016","unstructured":"Harper D, Chandler B. Splanchnic circulation. BJA Educ. 2016;16:66\u201371.","journal-title":"BJA Educ"},{"key":"217_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00210-007-0179-1","volume":"376","author":"CM Villal\u00f3n","year":"2007","unstructured":"Villal\u00f3n CM, Centuri\u00f3n D. Cardiovascular responses produced by 5-hydroxytriptamine: a pharmacological update on the receptors\/mechanisms involved and therapeutic implications. Naunyn Schmiede Arch Pharmacol. 2007;376:45\u201363.","journal-title":"Naunyn Schmiede Arch Pharmacol"},{"key":"217_CR7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1124\/pr.111.004697","volume":"64","author":"SW Watts","year":"2012","unstructured":"Watts SW, Morrison SF, Davis RP, Barman SM. Serotonin and blood pressure regulation. Pharmacol Rev. 2012;64:359\u201388.","journal-title":"Pharmacol Rev"},{"key":"217_CR8","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/sj.bjp.0701714","volume":"123","author":"A Mor\u00e1n","year":"1998","unstructured":"Mor\u00e1n A, Fern\u00e1ndez MM, Velasco C, Mart\u00edn ML, San Rom\u00e1n L. Characterization of prejunctional 5-HT1 receptors that mediate the inhibition of pressor effects elicited by sympathetic stimulation in the pithed rat. Br J Pharmacol. 1998;123:1205\u201313.","journal-title":"Br J Pharmacol"},{"key":"217_CR9","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1016\/S0024-3205(99)00126-5","volume":"64","author":"CM Villal\u00f3n","year":"1999","unstructured":"Villal\u00f3n CM, Centuri\u00f3n D, Fern\u00e1ndez MM, Mor\u00e1n A, S\u00e1nchez-L\u00f3pez A. 5-Hydroxytryptamine inhibits the tachycardia induced by selective preganglionic sympathetic stimulation in pithed rats. Life Sci. 1999;64:1839\u201347.","journal-title":"Life Sci"},{"key":"217_CR10","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/j.1440-1681.2010.04281.x","volume":"32","author":"E Calama","year":"2005","unstructured":"Calama E, Ort\u00edz de Urbina AV, Mor\u00e1n A, Mart\u00edn ML, San Rom\u00e1n L. Effect of 5-hydroxytryptamine on neurogenic vasoconstriction in the isolated, autoperfused hindquarters of the rat. Clin Exp Pharmacol Physiol. 2005;32:894\u2013900.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"217_CR11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.vph.2015.05.003","volume":"72","author":"JA Garc\u00eda-Pedraza","year":"2015","unstructured":"Garc\u00eda-Pedraza JA, Garc\u00eda M, Mart\u00edn ML, Mor\u00e1n A. 5-HT1D receptor inhibits renal sympathetic neurotransmission by nitric oxide pathway in anesthetized rats. Vasc Pharmacol. 2015;72:172\u201380.","journal-title":"Vasc Pharmacol"},{"key":"217_CR12","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/1440-1681.12841","volume":"44","author":"JAacute Garc\u00eda-Pedraza","year":"2017","unstructured":"Garc\u00eda-Pedraza J\u00c1, Garc\u00eda-Domingo M, G\u00f3mez-Roso M, Rodr\u00edguez-Barbero A, Mart\u00edn ML, Mor\u00e1n A. 5-HT modulates the rat mesenteric vasopressor outflow by 5-HT1D sympatholytic receptors. Clin Exp Pharmacol Physiol. 2017;44:1224\u201331.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"217_CR13","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/00005344-199811000-00018","volume":"32","author":"Y Naito","year":"1998","unstructured":"Naito Y, Yoshida H, Konishi C, Ohara N. Differences in responses to norepinephrine and adenosine triphosphate in isolated perfused mesenteric vascular beds between normotensive and spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1998;32:807\u201318.","journal-title":"J Cardiovasc Pharmacol"},{"key":"217_CR14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1139\/y05-012","volume":"83","author":"R Tatchum-Talom","year":"2005","unstructured":"Tatchum-Talom R, Eyster KM, Martin DS. Sexual dimorphism in angiotensin II-induced hypertension and vascular alterations. Can J Physiol Pharmacol. 2005;83:413\u201322.","journal-title":"Can J Physiol Pharmacol"},{"key":"217_CR15","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","volume":"160","author":"JC McGrath","year":"2010","unstructured":"McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL. Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol. 2010;160:1573\u20136.","journal-title":"Br J Pharmacol"},{"key":"217_CR16","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1111\/j.1476-5381.1994.tb17147.x","volume":"113","author":"A Mor\u00e1n","year":"1994","unstructured":"Mor\u00e1n A, Velasco C, Salvador T, Mart\u00edn ML, San Rom\u00e1n L. Inhibitory 5-hydroxytryptamine receptors involved in pressor effects obtained by stimulation of sympathetic outflow from spinal cord in pithed rats. Br J Pharmacol. 1994;113:1358\u201362.","journal-title":"Br J Pharmacol"},{"key":"217_CR17","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/sj.bjp.0706216","volume":"145","author":"M Garc\u00eda","year":"2005","unstructured":"Garc\u00eda M, Mor\u00e1n A, Calama E, Mart\u00edn ML, Barthelmebs M, Rom\u00e1n L. Diabetes induced changes in the 5-hydroxytryptamine inhibitory receptors involved in the pressor effect elicited by sympathetic stimulation in the pithed rat. Br J Pharmacol. 2005;145:593\u2013601.","journal-title":"Br J Pharmacol"},{"key":"217_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0014-2999(00)00444-1","volume":"401","author":"MM Fern\u00e1ndez","year":"2000","unstructured":"Fern\u00e1ndez MM, Mor\u00e1n A, Mart\u00edn ML, San Rom\u00e1n L. Mesenteric vasoconstrictor responses to 5-hydroxytryptamine in the in situ blood autoperfused rat mesentery: involvement of 5-HT2B and\/or 5-HT2C receptor activation. Eur J Pharmacol. 2000;401:221\u20137.","journal-title":"Eur J Pharmacol"},{"key":"217_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ejphar.2009.08.026","volume":"620","author":"A Mor\u00e1n","year":"2009","unstructured":"Mor\u00e1n A, Ort\u00edz de Urbina AV, Mart\u00edn ML, Rodr\u00edguez-Barbero A, San Rom\u00e1n L. Characterization of contractile 5-hydroxytryptamine receptor in the autoperfused kidney of L-NAME hypertensive rats. Eur J Pharmacol. 2009;620:90\u20136.","journal-title":"Eur J Pharmacol"},{"key":"217_CR20","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1111\/j.1476-5381.2012.01935.x","volume":"166","author":"H Fujii","year":"2012","unstructured":"Fujii H, Takatori S, Zamami Y, Hashikawa-Hobara N, Miyake N, Tangsucharit P, et al. Adrenergic stimulation-released 5-HT stored in adrenergic nerves inhibits CGRPergic nerve-mediated vasodilatation in rat mesenteric resistance arteries. Br J Pharmacol. 2012;166:2084\u201394.","journal-title":"Br J Pharmacol"},{"key":"217_CR21","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1172\/JCI115849","volume":"90","author":"C Baylis","year":"1992","unstructured":"Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest. 1992;90:278\u201381.","journal-title":"J Clin Invest"},{"key":"217_CR22","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1152\/physrev.00004.2012","volume":"93","author":"PN Hopkins","year":"2013","unstructured":"Hopkins PN. Molecular biology of atherosclerosis. Physiol Rev. 2013;93:1317\u2013542.","journal-title":"Physiol Rev"},{"key":"217_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1124\/jpet.102.037390","volume":"303","author":"A Rusell","year":"2002","unstructured":"Rusell A, Banes A, Berlin HD, Fink G, Watts SW. 5-Hydroxytryptamine 2B receptor function is enhanced in the L-NAME hypertensive rats. J Pharmacol Exp Ther. 2002;303:179\u201389.","journal-title":"J Pharmacol Exp Ther"},{"key":"217_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0895-7061(02)03144-8","volume":"16","author":"I Rodriguez-Gomez","year":"2003","unstructured":"Rodriguez-Gomez I, Wangensteen R, Atucha NM, O\u2019Valle F, Del Moral RG, Garcia-Esta\u00f1 J, et al. Effect of omapatrilat on blood pressure and renal injury in the L-NAME and L-NAME plus DOCA-treated rats. Am J Hypertens. 2003;16:33\u20138.","journal-title":"Am J Hypertens"},{"key":"217_CR25","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1152\/ajprenal.00374.2004","volume":"288","author":"DL Mattson","year":"2005","unstructured":"Mattson DL, Kunert MP, Roman RJ, Jacob HJ, Coeley AW Jr. Substitution of chromosome 1 ameliorates L-NAME hypertension and renal disease in the fawnhooded hypertensive rat. Am J Physiol Ren Physiol. 2005;288:1015\u201322.","journal-title":"Am J Physiol Ren Physiol"},{"key":"217_CR26","first-page":"33","volume":"16","author":"L Paulis","year":"2008","unstructured":"Paulis L, Zicha J, Kunes J, Hojna S, Behuliak M, Celec P, et al. Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor. Hypertension. 2008;16:33\u20138.","journal-title":"Hypertension"},{"key":"217_CR27","first-page":"1241","volume":"23","author":"DA Kasal","year":"2008","unstructured":"Kasal DA, Neves MF, Oigman W, Mandarin de Lacerda CA. Allopurinol attenuates L-NAME induced cardiomyopathy comparable to blockade of angiotensin receptor. Histol Histopathol. 2008;23:1241\u20138.","journal-title":"Histol Histopathol"},{"key":"217_CR28","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1152\/ajprenal.00621.2007","volume":"295","author":"Y Kanematsu","year":"2008","unstructured":"Kanematsu Y, Yamaguchi K, Ohnishi H, Motobayashi Y, Ishizawa K, Izawa Y, et al. Dietary doses of nitrite restore the circulating nitric oxide level and improve renal injury in L-NAME-induced hypertensive rats. Am J Physiol Ren Physiol. 2008;295:1457\u201362.","journal-title":"Am J Physiol Ren Physiol"},{"key":"217_CR29","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1111\/j.1476-5381.1995.tb13369.x","volume":"114","author":"YX Wang","year":"1995","unstructured":"Wang YX, Lim SL, Pang CC. Increase by NG-nitro-L-arginine methyl ester (L-NAME) of resistance to venous return in rats. Br J Pharmacol. 1995;114:1454\u20138.","journal-title":"Br J Pharmacol"},{"key":"217_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/01.HYP.14.1.44","volume":"14","author":"T Hano","year":"1989","unstructured":"Hano T, Rho J. Norepinephrine overflow in perfused mesenteric arteries of spontaneously hypertensive rats. Hypertension. 1989;14:44\u201353.","journal-title":"Hypertension"},{"key":"217_CR31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1536\/ihj.31.393","volume":"31","author":"T Inoue","year":"1990","unstructured":"Inoue T, Masuda T, Kishi K. Structural and functional alterations of mesenteric vascular beds in spontaneously hypertensive rats. Jpn Heart J. 1990;31:393\u2013403.","journal-title":"Jpn Heart J"},{"key":"217_CR32","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0014-2999(97)01006-6","volume":"330","author":"A Mor\u00e1n","year":"1997","unstructured":"Mor\u00e1n A, Velasco C, Mart\u00edn ML, San Rom\u00e1n L. Renal vasoconstrictor response to 5-hydroxytryptamine in the in situ autoperfused rat kidney: Involvement of angiotensin II and the 5-HT2 receptor activation. Eur J Pharmacol. 1997;330:205\u201311.","journal-title":"Eur J Pharmacol"},{"key":"217_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ejphar.2008.06.106","volume":"592","author":"A Mor\u00e1n","year":"2008","unstructured":"Mor\u00e1n A, Ort\u00edz de Urbina AV, Mart\u00edn ML, Garc\u00eda M, Rodr\u00edguez-Barbero A, Dorado F, et al. Characterization of contractile 5-hydroxytryptamine receptor subtypes in the in situ autoperfused kidney in the anaesthetized rat. Eur J Pharmacol. 2008;592:133\u20137.","journal-title":"Eur J Pharmacol"},{"key":"217_CR34","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/1440-1681.12397","volume":"42","author":"JAacute Garc\u00eda-Pedraza","year":"2015","unstructured":"Garc\u00eda-Pedraza J\u00c1, Garc\u00eda M, Mart\u00edn ML, Mor\u00e1n A. Pharmacological evidence that 5-HT1D activation induces renal vasodilation by NO pathway in rats. Clin Exp Pharmacol Physiol. 2015;42:640\u20137.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"217_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.pharmthera.2004.08.005","volume":"104","author":"T Nagatomo","year":"2004","unstructured":"Nagatomo T, Rashid M, Abul Muntasir H, Komiyama T. Functions of 5-HT2A receptor and its antagonists in the cardiovascular system. Pharmacol Ther. 2004;104:59\u201381.","journal-title":"Pharmacol Ther"},{"key":"217_CR36","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/j.1552-4604.1997.tb04299.x","volume":"37","author":"YY Huang","year":"1997","unstructured":"Huang YY, Hsu BR, Tsai JS. Effect of cisapride, a serotonin-4 receptor agonist, on aldosterone secretion: absence of age-related change. J Clin Pharmacol. 1997;37:1146\u20139.","journal-title":"J Clin Pharmacol"},{"key":"217_CR37","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.1021\/acs.jmedchem.8b00457","volume":"61","author":"R Nirogi","year":"2018","unstructured":"Nirogi R, Mohammed AR, Shinde AK, Gagginapally SR, Kancharla DM, Middekadi VR. et al. Synthesis, structure-activity relationships, and preclinical evaluation of heteroaromatic amides and 1,3,4-oxadiazole derivatives as 5-HT4 receptor partial agonists. J Med Chem. 2018;61:4993\u20135008.","journal-title":"J Med Chem"},{"key":"217_CR38","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1161\/01.CIR.72.4.728","volume":"72","author":"PM Vanhoutte","year":"1985","unstructured":"Vanhoutte PM, Houston DC. Platelets, endothelium, and vasospasm. Circulation. 1985;72:728\u201334.","journal-title":"Circulation"},{"key":"217_CR39","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejphar.2010.06.013","volume":"643","author":"A Mor\u00e1n","year":"2010","unstructured":"Mor\u00e1n A, Restrepo B, Ort\u00edz de Urbina AV, Garc\u00eda M, Mart\u00edn ML, Rom\u00e1n LS. Pharmacological profile of 5-hydroxytryptamine-induced inhibition on the pressor effect elicited by sympathetic stimulation in long-term diabetic pithed rats. Eur J Pharmacol. 2010;643:70\u20137.","journal-title":"Eur J Pharmacol"},{"key":"217_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejphar.2011.03.006","volume":"659","author":"B Restrepo","year":"2011","unstructured":"Restrepo B, Garc\u00eda M, Rodr\u00edguez-Barbero A, Rom\u00e1n LS, Mart\u00edn ML, Mor\u00e1n A. Participation of cyclooxygenase pathway in the vasoconstriction induced by 5-HT in the in situ autoperfused kidney of long-term diabetic rats. Eur J Pharmacol. 2011;659:37\u201344.","journal-title":"Eur J Pharmacol"},{"key":"217_CR41","first-page":"19","volume":"8","author":"OE Brodde","year":"1990","unstructured":"Brodde OE. 5-Hydroxytryptamine-receptor subtypes. Clin Physiol Biochem. 1990;8:19\u201327.","journal-title":"Clin Physiol Biochem"},{"key":"217_CR42","first-page":"188","volume":"58","author":"GJ Molderings","year":"2006","unstructured":"Molderings GJ, Br\u00fcss M, G\u00f6thert M. Functional and molecular identification of 5-hydroxytryptamine receptors in rabbit pulmonary artery: involvement in complex regulation of noradrenaline release. Pharmacol Rep. 2006;58:188\u201399.","journal-title":"Pharmacol Rep"},{"key":"217_CR43","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1006\/mvre.2000.2275","volume":"60","author":"NG McHale","year":"2000","unstructured":"McHale NG, Thornbury KD, Hollywood MA. 5-HT inhibits spontaneous contractility of isolated sheep mesenteric lymphatics via activation of 5-HT(4) receptors. Microvasc Res. 2000;60:261\u20138.","journal-title":"Microvasc Res"},{"key":"217_CR44","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","volume":"132","author":"MD Gershon","year":"2007","unstructured":"Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology. 2007;132:397\u2013414.","journal-title":"Gastroenterology"},{"key":"217_CR45","doi-asserted-by":"publisher","first-page":"H676","DOI":"10.1152\/ajpheart.00165.2017","volume":"313","author":"BM Seitz","year":"2017","unstructured":"Seitz BM, Orer HS, Krieger-Burke T, Darios ES, Thompson JM, Fink GD, et al. 5-HT causes splanchnic venodilation. Am J Physiol Heart Circ Physiol. 2017;313:H676\u201386.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"217_CR46","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ejphar.2015.02.032","volume":"754","author":"ES Darios","year":"2015","unstructured":"Darios ES, Barman SM, Orer HS, Morrison SF, Davis RP, Seitz BM, et al. 5-Hydroxytryptamine does not reduce sympathetic nerve activity or neuroeffector function in the splanchnic circulation. Eur J Pharmacol. 2015;754:140\u20137.","journal-title":"Eur J Pharmacol"},{"key":"217_CR47","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0014-2999(80)90145-4","volume":"66","author":"EK Jackson","year":"1980","unstructured":"Jackson EK, Campbell B. The in situ blood perfused rat mesentery: a model for assessing modulation of adrenergic neurotransmission. Eur J Pharmacol. 1980;66:217\u201324.","journal-title":"Eur J Pharmacol"},{"key":"217_CR48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1254\/jphs.12266FP","volume":"122","author":"C Rocha-Pereira","year":"2013","unstructured":"Rocha-Pereira C, Arribas SM, Fresco P, Gonz\u00e1lez MC, Gon\u00e7alves J, Diniz C. Impaired inhibitory function of presynaptic A1-adenosine receptors in SHR mesenteric arteries. J Pharmacol Sci. 2013;122:59\u201370.","journal-title":"J Pharmacol Sci"},{"key":"217_CR49","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1161\/HYPERTENSIONAHA.111.00474","volume":"61","author":"JD Foss","year":"2013","unstructured":"Foss JD, Fink GD, Osborn JW. Reversal of genetic salt-sensitive hypertension by targeted sympathetic ablation. Hypertension. 2013;61:806\u201311.","journal-title":"Hypertension"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0217-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0217-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0217-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:20:21Z","timestamp":1684617621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-019-0217-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,29]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["217"],"URL":"https:\/\/doi.org\/10.1038\/s41440-019-0217-7","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,29]]},"assertion":[{"value":"2 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}